GRIFOLS | GRF - Assets


GRIFOLS reported EUR20.08B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alcon AG USD 31.62B 64M Mar/2026
Almirall EUR 2.34B 29.21M Dec/2025
Amadeus IT EUR 11.43B 44.1M Mar/2026
Amarin USD 645.76M 25.01M Mar/2026
argenx SE USD 8.68B 1.51B Dec/2025
AstraZeneca USD 114.02B 59M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Cie Automotive EUR 5.68B 97.53M Dec/2025
Demant DKK 39.07B 6.43B Dec/2025
Ence Energia y Celulosa EUR 1.64B 55.33M Dec/2025
Essilor EUR 63.9B 1.97B Dec/2025
Ferrovial EUR 27.42B 857M Dec/2025
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Inditex EUR 36.49B 851M Mar/2026
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Philips EUR 27.27B 322M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Smith & Nephew USD 10.69B 150M Dec/2025
UCB EUR 18.16B 971M Dec/2025
Viscofan EUR 1.52B 74.13M Mar/2026